Novel exendin and exendin agonist compound formulations and dosages and methods
of administration thereof are provided. These compositions and methods are useful
in treating diabetes and conditions that would be benefited by lowering plasma
glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
